Terminology Service for NFDI4Health
All terms in NCIT
| Label | Id | Description |
|---|---|---|
| Nasopharyngeal Cancer pN2 TNM Finding v7 | NCIT_C88973 | [Nasopharyngeal cancer with bilateral metastasis in cervical lymph node(s), 6 cm or less in greatest dimension, above the supraclavicular fossa. Midline nodes are considered ipsilateral nodes. (from AJCC 7th Ed.)] |
| Nasopharyngeal Cancer pN3 TNM Finding v7 | NCIT_C88974 | [Nasopharyngeal cancer with metastasis in a lymph node (s) more than 6 cm in greatest dimension and/or to supraclavicular fossa. Supraclavicular zone or fossa is relevant to the staging of nasopharyngeal carcinoma and is the triangular region originally described by Ho. It is defined by three points: (1) the superior margin of the sternal end of the clavicle, (2) the superior margin of the lateral end of the clavicle, (3) the point where the neck meets the shoulder. This would include caudal portions of levels IV and VB. All cases with lymph nodes (whole or part) in the fossa are considered N3b. (from AJCC 7th Ed.)] |
| Nasopharyngeal Cancer pN3b TNM Finding v7 | NCIT_C88975 | [Nasopharyngeal cancer with extension to the supraclavicular fossa. Supraclavicular zone or fossa is relevant to the staging of nasopharyngeal carcinoma and is the triangular region originally described by Ho. It is defined by three points: (1) the superior margin of the sternal end of the clavicle, (2) the superior margin of the lateral end of the clavicle, (3) the point where the neck meets the shoulder. This would include caudal portions of levels IV and VB. All cases with lymph nodes (whole or part) in the fossa are considered N3b. (from AJCC 7th Ed.)] |
| Brosotamide | NCIT_C74330 | |
| Nonsteroidal Antiinflammatory Drug | NCIT_C257 | [A pharmacological agent that is not a steroid and has potential anti-inflammatory, analgesic, antipyretic and anti-platelet activities. Most nonsteroidal anti-inflammatory drugs (NSAIDs) act by inhibiting the conversion of arachidonic acid to the precursors of prostaglandin and thromboxane by cyclooxygenase enzymes.] |
| Aloracetam | NCIT_C74324 | |
| Neuroprotective Agent | NCIT_C1509 | [A pharmacological agent that protects the central nervous system from damage caused by acute ischemia or chronic neurodegenerative diseases.] |
| EntrezGene_ID | NCIT_C49379 | [Indicates the accession number for a Gene within the Entrez Gene database.] |
| NCI Thesaurus Property | NCIT_C43644 | [A specific terminology property present in the NCI Thesaurus.] |
| Nefiracetam | NCIT_C74325 | |
| Ipramidil | NCIT_C74326 | |
| Enprofylline | NCIT_C74327 | |
| Sambucus ebulus | NCIT_C74320 | |
| PLA2G6 wt Allele | NCIT_C49375 | [Human PLA2G6 wild-type allele is located in the vicinity of 22q13.1 and is approximately 75 kb in length. This allele, which encodes 85 kDa calcium-independent phospholipase A2 protein, plays a role in the hydrolysis of phosphatidylcholine.] |
| PLA2G6 Gene | NCIT_C38597 | [This gene plays a role in apoptosis and membrane remodeling.] |
| Trifolium pratense | NCIT_C74321 | |
| BNIP3L wt Allele | NCIT_C49376 | [Human BNIP3L wild-type allele is located in the vicinity of 8p21 and is approximately 28 kb in length. This allele, which encodes BCL2/adenovirus E1B 19-kDa protein-interacting protein 3-like protein, plays a role in the promotion of apoptosis and may be involved in tumor suppression.] |
| Citrullus colocynthis | NCIT_C74322 | |
| DROSHA wt Allele | NCIT_C49377 | [Human DROSHA wild-type allele is located in the vicinity of 5p13.3 and is approximately 132 kb in length. This allele, which encodes ribonuclease 3 protein, plays a role in the initiation of microRNA processing. Somatic mutation of the gene may be associated with kidney cancer.] |
| DROSHA Gene | NCIT_C25955 | [This gene plays a role in the processing of microRNA in the nucleus.] |